Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Abajian, Henry B."'
Autor:
Gabriela Nicolau, John P. Feighner, Abajian Henry B, Joseph J. Hlavka, George Tonelli, Jeffrey S. Freed, Lev Sverdlov
Publikováno v:
The International Journal of Neuropsychopharmacology. 6:207-213
Data from two Phase 2 clinical studies with nemifitide, a novel pentapeptide antidepressant, were evaluated. The initial double-blind, placebo-controlled study was performed on outpatients with DSM-IV criteria for major depressive disorder. An open-l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00a41db90c2e64571a6bcaae669a6a9d
https://doi.org/10.1017/s1461145703003481
https://doi.org/10.1017/s1461145703003481
Autor:
Joseph J. Hlavka, John P. Feighner, Lev Sverdlov, Nadia Cardillo Marricco, Abajian Henry B, Gabriela Nicolau, Carlo Di Spirito, George Tonelli, John Morrison, George Faria
Publikováno v:
Biopharmaceutics & Drug Disposition. 23:33-39
Nemifitide (4-fluoro-L-phenylalanyl-trans-4-hydroxy-L-prolyl-L-arginylglycyl-L-tryptophanamide ditrifluoroacetate) is a novel antidepressant, currently in phase 2/3 clinical trials. The purpose of our phase 1 clinical trials (conducted over a three y
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72cbde9cf5f5807012f9c994331d5701
https://doi.org/10.1002/bdd.290
https://doi.org/10.1002/bdd.290
Autor:
Feighner, John P., Sverdlov, Lev, Nicolau, Gabriela, Abajian, Henry B., Hlavka, Joseph, Freed, Jeffrey S., Tonelli, George
Publikováno v:
The International Journal of Neuropsychopharmacology; September 2003, Vol. 6 Issue: 3 p207-207, 1p